Profile
TRIB DHR-PB TMO DHR IDXX A
Company Name Trinity Biotech plc Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $16.83M $916.76B $183.06B $151.04B $52.07B $33.86B
Employees 0.38K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO John Gillard Rainer M. Blair Marc N. Casper Rainer M. Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
TRIB DHR-PB TMO DHR IDXX A
Quant Rating Score 2 5 3 3 3 4
Quant Rating Sell Strong Buy Neutral Neutral Neutral Buy
Trading
TRIB DHR-PB TMO DHR IDXX A
Last Close $1.62 $1261.26 $489.01 $210.93 $650.84 $119.2
High 52 $2.5 $1261.26 $624.21 $278.02 $682.78 $152.6
Low 52 $0.53 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High -35.2 % 0 % -21.66 % -24.13 % -4.68 % -21.89 %
Price vs. 52 Week Low 205.66 % 0 % 25.32 % 20.78 % 80.27 % 20.05 %
Total Return
TRIB DHR-PB TMO DHR IDXX A
1 Month Return 121.71 % 0 % 17.9 % 10.99 % 26.47 % 4.57 %
3 Month Return 91.22 % 0 % 18.67 % 7.56 % 25.62 % 4.77 %
6 Month Return 109.84 % 0 % -6.52 % 3.13 % 44.93 % -11.83 %
9 Month Return 22.73 % 0 % -3.95 % -8.63 % 56.32 % -5.16 %
YTD Return 84.05 % 0 % -6 % -8.11 % 57.42 % -11.27 %
1 Year Return -33.06 % 0 % -19.04 % -21.68 % 32.21 % -14.88 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TRIB DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.56 % 0.34 % 0.56 % - 0.82 %
Dividend Paid and Capex Coverage Ration (TTM) -0.62 % 2.91 % 3.76 % 2.91 % 6.89 % 2.36 %
Dividend Per Share (TTM) - 1.18 % 1.64 % 1.18 % - 0.98 %
Payout Ratio (TTM) - 23.85 % 9.26 % 23.85 % - 23.76 %
Profitability
TRIB DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 33.98 % 61.52 % 39.58 % 61.52 % 61.54 % 53.35 %
Return on Assets TTM -30.78 % 4.18 % 6.5 % 4.18 % 29.59 % 9.59 %
Return on Equity TTM 111.76 % 6.69 % 13.27 % 6.69 % 64.42 % 19.46 %
Return on Capital Employed TTM -29.77 % 6.93 % 8.97 % 6.93 % 59.57 % 13.97 %
Net Income Per EBT TTM 103.45 % 83.73 % 93.8 % 83.73 % 80.28 % 85.05 %
EBT Per Ebit TTM 144.99 % 78.61 % 88.39 % 78.61 % 97.81 % 96.75 %
EBIT Per Revenue TTM -34.43 % 21.59 % 18.38 % 21.59 % 31.09 % 21.38 %
Cash Flow To Debt Ratio TTM -6.15 % 33.25 % 21.51 % 33.25 % 73.21 % 45.35 %
Receivables Turnover TTM 4.22 5.32 4.31 5.32 6.09 4.85
Payables Turnover TTM 5.95 5.36 8.76 5.36 13.32 5.98
Inventory Turnover TTM 2.1 3.44 4.7 3.44 3.96 3.12
Fixed Asset Turnover TTM 1332.09 % 374.68 % 448.49 % 374.68 % 464.4 % 346.65 %
Asset Turnover TTM 59.6 % 29.42 % 42.69 % 29.42 % 121.22 % 54.52 %
Operating Cash Flow Per Share TTM -0.44 8.61 20.05 8.61 11.26 5.56
Free Cash Flow Per Share TTM -1.15 6.79 16.32 6.79 9.63 4.17
Cash Per Share TTM 36.46 % 412.7 % 1690.48 % 412.7 % 204.69 % 521.4 %
Operating Cash Flow Sales Ratio TTM -10.07 % 25.69 % 17.54 % 25.69 % 22.43 % 23.91 %
Free Cash Flow Operating Cash Flow Ratio TTM 262.44 % 78.81 % 81.42 % 78.81 % 85.49 % 75.02 %
Cash Flow Coverage Ratios TTM -6.15 % 33.25 % 21.51 % 33.25 % 73.21 % 45.35 %
Price To Free Cash Flows Ratio TTM -1.03 31.06 29.67 31.06 67.24 28.48
Price To Operating Cash Flows Ratio TTM -3.71 24.5 24.18 24.5 57.78 21.43
Price Cash Flow Ratio TTM -3.71 24.5 24.18 24.5 57.78 21.43
Income Statement (TTM)
TRIB DHR-PB TMO DHR IDXX A
Revenue $0.06B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $0.02B $14.21B $17.73B $14.21B $2.38B $3.54B
Gross Profit Ratio 34.83% 59.5% 41.34% 59.5% 61.04% 54.3%
EBITDA $-0.02B $7.28B $11.8B $7.28B $1.28B $1.87B
Net Income $-0.03B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted -1.8 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
TRIB DHR-PB TMO DHR IDXX A
Long Term Debt $0.1B $16.47B $30.3B $16.47B $0.55B $3.49B
Total Liabilities $0.14B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $-0.04B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $1.82B $2.12B $1.82B $0.06B $0.18B
Total Debt $0.1B $17.15B $32.78B $17.15B $0.99B $3.57B
Total Assets $0.1B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
TRIB DHR-PB TMO DHR IDXX A
Net Income $-0.03B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $-0B $0.15B $-0.03B $0.15B $-0.03B $0.03B
Dividends Paid $0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $-0B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0.01B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 119.12
ACRS Aclaris Therapeutics, Inc. 1.825
ADVB Advanced Biomed Inc. Common Stock 0.4275
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 3.8807
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.413
BIAF bioAffinity Technologies, Inc. 0.2416
BIAFW bioAffinity Technologies, Inc. 0.1
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 3.0944
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 10.18
CDNA CareDx, Inc 11.83
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.661
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 157.88
CSTL Castle Biosciences, Inc. 20.385
Unlock